867 related articles for article (PubMed ID: 23971943)
1. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
[TBL] [Abstract][Full Text] [Related]
2. Novel approaches for targeting the adenosine A2A receptor.
Yuan G; Gedeon NG; Jankins TC; Jones GB
Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
[TBL] [Abstract][Full Text] [Related]
3. Substructure-based virtual screening for adenosine A2A receptor ligands.
van der Horst E; van der Pijl R; Mulder-Krieger T; Bender A; Ijzerman AP
ChemMedChem; 2011 Dec; 6(12):2302-11. PubMed ID: 22021213
[TBL] [Abstract][Full Text] [Related]
4. Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: the human A₂A adenosine receptor as a key study.
Sabbadin D; Ciancetta A; Moro S
J Chem Inf Model; 2014 Jan; 54(1):169-83. PubMed ID: 24359090
[TBL] [Abstract][Full Text] [Related]
5. The integration of pharmacophore-based 3D QSAR modeling and virtual screening in safety profiling: A case study to identify antagonistic activities against adenosine receptor, A2A, using 1,897 known drugs.
Fan F; Toledo Warshaviak D; Hamadeh HK; Dunn RT
PLoS One; 2019; 14(1):e0204378. PubMed ID: 30605479
[TBL] [Abstract][Full Text] [Related]
6. Molecular docking screening using agonist-bound GPCR structures: probing the A2A adenosine receptor.
Rodríguez D; Gao ZG; Moss SM; Jacobson KA; Carlsson J
J Chem Inf Model; 2015 Mar; 55(3):550-63. PubMed ID: 25625646
[TBL] [Abstract][Full Text] [Related]
7. In search of novel ligands using a structure-based approach: a case study on the adenosine A
Lenselink EB; Beuming T; van Veen C; Massink A; Sherman W; van Vlijmen HW; IJzerman AP
J Comput Aided Mol Des; 2016 Oct; 30(10):863-874. PubMed ID: 27629350
[TBL] [Abstract][Full Text] [Related]
8. Novel adenosine A(2A) receptor ligands: a synthetic, functional and computational investigation of selected literature adenosine A(2A) receptor antagonists for extending into extracellular space.
Jörg M; Shonberg J; Mak FS; Miller ND; Yuriev E; Scammells PJ; Capuano B
Bioorg Med Chem Lett; 2013 Jun; 23(11):3427-33. PubMed ID: 23602401
[TBL] [Abstract][Full Text] [Related]
9. Docking Screens for Dual Inhibitors of Disparate Drug Targets for Parkinson's Disease.
Jaiteh M; Zeifman A; Saarinen M; Svenningsson P; Bréa J; Loza MI; Carlsson J
J Med Chem; 2018 Jun; 61(12):5269-5278. PubMed ID: 29792714
[TBL] [Abstract][Full Text] [Related]
10. Could the presence of sodium ion influence the accuracy and precision of the ligand-posing in the human A
Margiotta E; Deganutti G; Moro S
J Comput Aided Mol Des; 2018 Dec; 32(12):1337-1346. PubMed ID: 30361971
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of 2-hydrazinyladenosine derivatives as A(2A) adenosine receptor ligands.
El-Tayeb A; Gollos S
Bioorg Med Chem; 2013 Jan; 21(2):436-47. PubMed ID: 23245803
[TBL] [Abstract][Full Text] [Related]
12. Discovery of aminoquinazoline derivatives as human A(2A) adenosine receptor antagonists.
Zhou G; Aslanian R; Gallo G; Khan T; Kuang R; Purakkattle B; De Ruiz M; Stamford A; Ting P; Wu H; Wang H; Xiao D; Yu T; Zhang Y; Mullins D; Hodgson R
Bioorg Med Chem Lett; 2016 Feb; 26(4):1348-54. PubMed ID: 26781932
[TBL] [Abstract][Full Text] [Related]
13. Affinity Mass Spectrometry-Based Fragment Screening Identified a New Negative Allosteric Modulator of the Adenosine A
Lu Y; Liu H; Yang D; Zhong L; Xin Y; Zhao S; Wang MW; Zhou Q; Shui W
ACS Chem Biol; 2021 Jun; 16(6):991-1002. PubMed ID: 34048655
[TBL] [Abstract][Full Text] [Related]
14. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
Hoffer L; Renaud JP; Horvath D
J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
[TBL] [Abstract][Full Text] [Related]
15. Fragment screening of stabilized G-protein-coupled receptors using biophysical methods.
Congreve M; Rich RL; Myszka DG; Figaroa F; Siegal G; Marshall FH
Methods Enzymol; 2011; 493():115-36. PubMed ID: 21371589
[TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR and docking studies on adenosine A2A receptor antagonists by the CoMFA method.
Pourbasheer E; Shokouhi Tabar S; Masand VH; Aalizadeh R; Ganjali MR
SAR QSAR Environ Res; 2015 Jun; 26(6):461-77. PubMed ID: 26055215
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.
Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N
J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059
[TBL] [Abstract][Full Text] [Related]
18. Pharmacophore mapping and in silico screening to identify new potent leads for A(2A) adenosine receptor as antagonists.
Mustyala KK; Chitturi AR; Naikal James PS; Vuruputuri U
J Recept Signal Transduct Res; 2012 Apr; 32(2):102-13. PubMed ID: 22384789
[TBL] [Abstract][Full Text] [Related]
19. Docking Finds GPCR Ligands in Dark Chemical Matter.
Ballante F; Rudling A; Zeifman A; Luttens A; Vo DD; Irwin JJ; Kihlberg J; Brea J; Loza MI; Carlsson J
J Med Chem; 2020 Jan; 63(2):613-620. PubMed ID: 31846328
[TBL] [Abstract][Full Text] [Related]
20. Selecting an optimal number of binding site waters to improve virtual screening enrichments against the adenosine A2A receptor.
Lenselink EB; Beuming T; Sherman W; van Vlijmen HW; IJzerman AP
J Chem Inf Model; 2014 Jun; 54(6):1737-46. PubMed ID: 24835542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
